The conference will be conducted in English without translation.

Innovation in China - Chinese Government's Initiatives and Investments in the 12th 5-Year Plan
Hongguang Wang, Ph.D., Director General, China National Center for Biotech Development, Ministry of Science & Technology China

Key Factors to Be Successful in Emerging Markets
Ruiping Dong, M.D., Ph.D., Senior Vice President, Head of Emerging Markets R&D, Merck Research Laboratories

Innovation in Protein Therapeutics Research & Development
Clive R. Wood, Ph.D., Senior Vice President, Head of Global Biologics, Bayer Healthcare

How to Introduce the Concept of "Change" in Biopharmaceuticals
Sam Waskal, Ph.D., Chairman & CEO, Kadmon Pharmaceuticals

2nd Annual IBC-BayHelix China Pharma R&D Awards

IBC Life Sciences and BayHelix Group are pleased to host the 2nd Annual IBC-BayHelix China Pharma R&D Awards in honor and recognition of individuals and companies who have contributed to the advancement of China's pharmaceutical industry.

The following 3 Awards will be presented at the China 2011 Pharmaceutical R&D Summit, on Tuesday April 12, 2011 during the Luncheon:

• IBC China Scientific Discovery of the Year Award: recognizing the most significant discovery in life science in China
• IBC China Drug Discovery of the Year Award: recognizing the most significant achievement in new drug R&D milestones
• IBC China R&D Award: recognizing outstanding individuals whose contributions changed the landscape, reputation, and ecosystem for drug R&D in China